The Federal Circuit Reverses a Hindsight Reconstruction of An Important Pharmaceutical Invention
The Supreme Court Delivers a Win for Biosimilar Manufacturers in Sandoz v. Amgen
Filing an ANDA May Expose Generic Manufacturers to Nationwide Personal Jurisdiction in Patent Infringement Suits
Petitioners Beware: Improper Incorporation by Reference May Result in Truncated Petition
As Urged by PhRMA and BIO, Supreme Court Agrees to Review Claim Construction Standard Used in Patent Office Trials
As Urged by PhRMA and BIO, Supreme Court Agrees to Review Claim Construction Standard Used in Patent Office Trials
Patent Trial and Appeal Board Denies Inter Partes Review of Patent Claiming the Deuterated Form of a Known Compound
The USPTO Global Dossier Service Is Scheduled to Go Live in Mid-November
Subscribe: Subscribe via RSS
Firm/Org